JP2014502143A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014502143A5 JP2014502143A5 JP2013532945A JP2013532945A JP2014502143A5 JP 2014502143 A5 JP2014502143 A5 JP 2014502143A5 JP 2013532945 A JP2013532945 A JP 2013532945A JP 2013532945 A JP2013532945 A JP 2013532945A JP 2014502143 A5 JP2014502143 A5 JP 2014502143A5
- Authority
- JP
- Japan
- Prior art keywords
- rsv
- polypeptide
- seq
- vlp
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39059110P | 2010-10-06 | 2010-10-06 | |
| US61/390,591 | 2010-10-06 | ||
| PCT/US2011/055113 WO2012048115A2 (en) | 2010-10-06 | 2011-10-06 | Polypeptides and their use in treating and limiting respiratory syncytial virus infection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014502143A JP2014502143A (ja) | 2014-01-30 |
| JP2014502143A5 true JP2014502143A5 (enExample) | 2014-10-30 |
| JP6023061B2 JP6023061B2 (ja) | 2016-11-09 |
Family
ID=44993163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013532945A Expired - Fee Related JP6023061B2 (ja) | 2010-10-06 | 2011-10-06 | ポリペプチド、ならびに呼吸器多核体ウイルス感染症の治療および制限における該ポリペプチドの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9718862B2 (enExample) |
| EP (1) | EP2625194B1 (enExample) |
| JP (1) | JP6023061B2 (enExample) |
| CN (1) | CN103282378B (enExample) |
| AU (1) | AU2011311946B8 (enExample) |
| CA (1) | CA2813752A1 (enExample) |
| WO (1) | WO2012048115A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2625194B1 (en) | 2010-10-06 | 2015-08-12 | University Of Washington Through Its Center For Commercialization | Polypeptides and their use in treating and limiting respiratory syncytial virus infection |
| US9701720B2 (en) | 2012-04-05 | 2017-07-11 | University Of Washington Through Its Center For Commercialization | Epitope-scaffold immunogens against respiratory syncytial virus (RSV) |
| EP4582098A2 (en) * | 2015-11-09 | 2025-07-09 | CureVac SE | Optimized nucleic acid molecules |
| AU2018285412B2 (en) | 2017-06-14 | 2022-06-23 | Universität Zürich | Cyclic peptides for protection against respiratory syncytial virus |
| AU2019408048A1 (en) | 2018-12-20 | 2021-06-24 | Universität Zürich | Lipopeptide building blocks and synthetic virus-like particles |
| CN110853704B (zh) * | 2019-11-11 | 2020-11-06 | 腾讯科技（深圳）有限公司 | 蛋白质数据获取方法、装置、计算机设备及存储介质 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5334394A (en) | 1990-06-22 | 1994-08-02 | The Regents Of The University Of California | Human immunodeficiency virus decoy |
| US5770380A (en) | 1996-09-13 | 1998-06-23 | University Of Pittsburgh | Synthetic antibody mimics--multiple peptide loops attached to a molecular scaffold |
| US7138103B2 (en) * | 1998-06-22 | 2006-11-21 | Immunomedics, Inc. | Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| CN1193791C (zh) | 1998-11-30 | 2005-03-23 | 希托斯生物技术股份公司 | 抗原的有序分子呈递,制备及使用的方法 |
| AU2002327171A1 (en) | 2001-05-01 | 2003-01-02 | Medimmune, Inc. | Crystals and structure of synagis fab |
| CN105566497A (zh) | 2002-05-10 | 2016-05-11 | 新世纪药品有限公司 | 融合铁蛋白在疫苗和其他方面的应用 |
| CA2580921C (en) | 2004-09-21 | 2016-04-12 | Medimmune, Inc. | Antibodies against and methods for producing vaccines for respiratory syncytial virus |
| EP2062180A2 (en) | 2006-08-25 | 2009-05-27 | The Government of the United States of America as Represented by The Department of Health and Human Services | Epitope-protein scaffolds and their use |
| US8563002B2 (en) * | 2007-12-24 | 2013-10-22 | Glaxosmithkline Biologicals, S.A. | Recombinant RSV antigens |
| US20120034254A1 (en) | 2008-02-07 | 2012-02-09 | Kwong Peter D | Antigenic cloaking and its use |
| US8580270B2 (en) | 2008-09-30 | 2013-11-12 | University Of Massachusetts | Respiratory synctial virus (RSV) sequences for protein expression and vaccines |
| WO2011050168A2 (en) | 2009-10-21 | 2011-04-28 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic | Rsv immunogens, antibodies and compositions thereof |
| EP2625194B1 (en) | 2010-10-06 | 2015-08-12 | University Of Washington Through Its Center For Commercialization | Polypeptides and their use in treating and limiting respiratory syncytial virus infection |
| US9701720B2 (en) | 2012-04-05 | 2017-07-11 | University Of Washington Through Its Center For Commercialization | Epitope-scaffold immunogens against respiratory syncytial virus (RSV) |
-
2011
- 2011-10-06 EP EP11773937.5A patent/EP2625194B1/en not_active Not-in-force
- 2011-10-06 JP JP2013532945A patent/JP6023061B2/ja not_active Expired - Fee Related
- 2011-10-06 WO PCT/US2011/055113 patent/WO2012048115A2/en not_active Ceased
- 2011-10-06 CN CN201180058569.8A patent/CN103282378B/zh not_active Expired - Fee Related
- 2011-10-06 US US13/878,122 patent/US9718862B2/en not_active Expired - Fee Related
- 2011-10-06 CA CA2813752A patent/CA2813752A1/en active Pending
- 2011-10-06 AU AU2011311946A patent/AU2011311946B8/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12239699B2 (en) | Immunogen for broad-spectrum influenza vaccine and application thereof | |
| JP6949027B2 (ja) | ジカウイルスワクチン | |
| CN113666990B (zh) | 一种诱导广谱抗冠状病毒的t细胞疫苗免疫原及其应用 | |
| JP2014502143A5 (enExample) | ||
| JP2010166921A5 (enExample) | ||
| Jiang et al. | Hantavirus Gc induces long-term immune protection via LAMP-targeting DNA vaccine strategy | |
| CN104293741A (zh) | 一种呼吸道合胞病毒病毒样颗粒疫苗及其制备方法和应用 | |
| JP2019506175A5 (enExample) | ||
| WO2023023940A1 (zh) | 一种诱导广谱抗冠状病毒的t细胞疫苗免疫原及其应用 | |
| CN102127554B (zh) | 一种日本脑炎颗粒疫苗及其制备方法和应用 | |
| CN107344969A (zh) | 一种纳米流感疫苗及构建方法和应用 | |
| JP2012517239A5 (enExample) | ||
| CN103316357B (zh) | 携带rsv基因的重组流感病毒嵌合疫苗及其制备方法 | |
| RU2018103757A (ru) | Рекомбинантные вирусоподобные частицы (vlp) с использованием протеина группового антигена (gag) вируса бычьего иммунодефицита | |
| Madhukalya et al. | Nipah virus: pathogenesis, genome, diagnosis, and treatment | |
| CN117683137A (zh) | 靶向新城疫病毒和h9亚型禽流感病毒的重组双特异性纳米抗体及其制备方法和应用 | |
| CN103298936A (zh) | 具有新型流感病毒来源的血凝素蛋白基因的重组痘苗病毒 | |
| CN111514287A (zh) | 甲型流感通用型dna疫苗及其制备方法和应用 | |
| CN118421571A (zh) | 表达尼帕病毒囊膜糖蛋白的嵌合型vsv重组病毒及其应用 | |
| CN117398456A (zh) | 一种特异性标记异源蛋白的肿瘤新抗原疫苗体系及其应用 | |
| CN102813920A (zh) | 一种疫苗佐剂 | |
| Albalaty et al. | SARS-CoV-2 vaccines from A to Z: A review of the current challenges | |
| CN103980352B (zh) | 一种用于抑制鹅坦布苏病毒感染细胞的多肽及其应用 | |
| CN102943087A (zh) | 兔出血症病毒新型亚单位疫苗及其制备方法 | |
| CA3221953A1 (en) | Broadly reactive viral antigens as immunogens, compositions and methods of use thereof |